Navigation Links
Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
Date:4/20/2009

- Updated Data from Initial Cohort Shows 11 of 17 Evaluable Patients Receiving Bavituximab in Combination with Carboplatin + Paclitaxel Achieved an Objective Tumor Response -

- Patient Dosing Initiated in Expansion Stage of Trial with Target of Enrolling 49 Patients Overall -

TUSTIN, Calif., April 20 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), today announced that updated preliminary data from the initial cohort of 21 patients in its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel showed that 11 of 17 evaluable patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) achieved an objective tumor response according to RECIST criteria, after completing the maximum six treatment cycles. The company also reported that patient dosing is underway in the expansion stage of the trial, which will enroll an additional 28 patients for a total of 49 patients overall.

"We are very pleased to see these additional objective tumor responses in this difficult-to-treat cancer following the full regimen of six treatment cycles of bavituximab and chemotherapy," said Steven W. King, president and CEO of Peregrine. "These updated results build on the impressive data we reported after only four treatment cycles, which had already exceeded the pre-defined number of objective tumor responses needed to expand the trial to the larger cohort."

Mr. King added, "The tumor response data to date from this trial compares favorably to published studies with current standard-of-care lung cancer treatments, and we are looking forward to seeing results from the entire study. With dosing now underway in the expanded patient cohort, we expect to resume the brisk pace of enrollment achieved in the first cohort, with the goal of completing patient
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
3. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
4. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
5. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
6. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
7. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
8. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
9. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
10. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... March 5, 2015 Bayer HealthCare announced today ... Conquer Cancer Foundation of the American Society of Clinical ... information technology platform designed to unlock vast quantities of ... "Bayer is proud to join ASCO ... leverage Big Data to help people whose lives have ...
(Date:3/5/2015)... NEW YORK , March 5, 2015 /PRNewswire/ ... real-time patient management solutions recognized for improving the ... announced today that Robert Anazagasty and ... Anazagasty will serve as Vice President, Strategic Client ... Enterprise Sales. These additions support AMC Health,s commitment ...
(Date:3/5/2015)... , March 5, 2015 LUNGevity ... the Food and Drug Administration,s (FDA) approval of ... Opdivo and other immunotherapy treatments add another critical ... harnessing the power of a patient,s own immune ... has been approved specifically for patients with squamous ...
Breaking Medicine Technology:Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3
... 23, 2012  AlloSource, one of the nation,s largest non-profit ... use in surgical procedures and the world,s largest processor ... Dale Bike as Vice President of Sales and Marketing. ... Sales and Marketing, Dale will lead the AlloSource direct ...
... The Academy of Managed Care Pharmacy (AMCP) has installed ... elected members: President-Elect Kim A. Caldwell and Directors David ... members on the new Board of Directors are: President ... Directors Steve Avey and Eric Cannon. All of the ...
Cached Medicine Technology:Industry Veteran Brings Sales Expertise to AlloSource's Growing Distribution Network 2Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors 2Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors 3Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors 4
(Date:3/5/2015)... A Bakersfield, Calif. state court jury returned a verdict ... plaintiff Coleen M. Perry a total of $5.7 million for ... mesh sling device, manufactured by Ethicon, Inc., a subsidiary of ... at Wagstaff & Cartmell in Kansas City, Mo., ... Rich Freese and Tim Goss of Freese & Goss ...
(Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased to announce ... logo and optimized website. , CNI’s new ... expert diagnostic imaging, centered on patient care. The new ... a resource for Nebraska patients and a tool for ... referral functionality, video content and resources to understand health ...
(Date:3/5/2015)... 05, 2015 On March 2, 2015, ... Labiaplasty on the Rise, Plastic Surgeons Say,” that comments ... Society for Aesthetic Plastic Surgery and the ... reported a year-over-year doubling of surgical butt augmentations performed ... in the article, this increase can be attributed to ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 At the ... and Beyond,” leaders in addiction treatment met today in ... in best clinical practices. Among the numerous respected speakers ... who will address the role that pain medications have ... new evidence-based treatment options. , "It is hard to ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 University ... university founded in 1904, has launched a new ... positive lifestyle changes. The Northwest Center for Lifestyle ... professionals, support community outreach, and conduct research in ... medicine, diet and nutrition. The center will target ...
Breaking Medicine News(10 mins):Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2
... Valentine,s Day gifts that truly demonstrate couple,s loveATLANTA, Feb. ... for couples to express their love for one another, ... convey this important message. But one pair of unique ... commitment to each other. This Valentine,s Day couples can ...
... MI based manufacturer of industrial parts cleaning systems and custom ... field. Midbrook’s Cart Washer for Central Processing was ... for Central Processing is a large capacity, fully automated, floor ... Processing Unit of hospitals. , ...
... consider supplemental insurance for ,critical illness coverage , ... Chicago (PRWEB) February ... their first heart attack in 2009 and, on average, every 40 seconds ... is a good time to consider not just your risk for heart ...
... dentists will give over 350 children a new smile! , ... (PRWEB) ... 350 children a new smile! The opportunity comes at a perfect ... Kentucky! , a community partnership that addresses the most common unmet health ...
... , ... Ann Arbor, MI (PRWEB) February 4, 2009 ... applications, announces revenue increased year-over-year by over 300 percent in 2008. ... base of clinician users by over 400 percent over the previous ...
... Niche, Healthcare-Career Site Recognized by Candidate Community , ... ... onTargetjobs Inc. (OTJ) company and North America,s premier healthcare ... named as this year,s top job sites., , , , ,"With ...
Cached Medicine News:Health News:When Flowers or a Tie Just Won't Do 2Health News:Midbrook Installs New Cart Washer for Central Processing in Local Hospital 2Health News:Know Your Risk and Insurance Coverage for Heart Attacks and Strokes 2Health News:Know Your Risk and Insurance Coverage for Heart Attacks and Strokes 3Health News:A New Smile: During Tough Economic Conditions Hundreds of Kentucky Children Receive Free Dental Care 2Health News:A New Smile: During Tough Economic Conditions Hundreds of Kentucky Children Receive Free Dental Care 3Health News:Cielo MedSolutions Announces Strong Revenue Growth in 2008 2Health News:HEALTHeCAREERS Network Receives WEDDLE's 2009 User's Choice Award 2
Wire mesh braided design with a platinum core....
... Finnpipette Focus multichannel pipettes ... of reagents into microplates, ... 0.1-10 l volumes. The ... Finnpipette Focus multichannels, combined ...
... The Finnpipette Digital Multichannel, ... even lighter work of routine ... all these advanced features: Soft-touch ... micro volume pipetting (0.5-10ul models), ...
... and Benefits: 1-12channel pipette This ... product number, created to easily ... showing no availability yet, please ... number (Z37,173-4) or contact customer ...
Medicine Products: